GLP 1 receptor agonists – obesity semaglutide-and-cardiovascular-outcomes-in-obese-non-diabetics-11-11-2023Download https://www.reuters.com/business/healthcare-pharmaceuticals/experimental-lilly-pill-leads-147-weight-loss-mid-stage-trial-2023-06-23/ https://pubmed.ncbi.nlm.nih.gov/35441470/ 25.1.2023: https://futurism.com/neoscope/mounjaro-ozempic-weight-loss-drug-aging-faces
ECIPA Healthcare 